Century Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -7.43%
- Market cap
- $294.19M
- 181.6M shares
- Filings
- 446
FY 2025+1,556.8% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+5.8% FY25 yoy
- $294.19M
- —
- 2.7×
- 1.4×
- -35.60%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $109,164,000 | reported | |
| FY 2024 | 2024-12-31 | $6,589,000 | reported | |
| FY 2023 | 2023-12-31 | $2,235,000 | reported | |
| FY 2022 | 2022-12-31 | $5,199,000 | reported |
Biological products, except diagnostic substances
Century Therapeutics, Inc. is the 30th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
BEAMBeam Therapeutics Inc.$139.7M120.0%57.2%$2.5BGLUEMonte Rosa Therapeutics, Inc.$123.7M63.5%31.2%$793.0MATRAAtara Biotherapeutics, Inc.$120.8M6.3%27.1%$80.4MAGENAgenus Inc$114.2M10.4%2.7%$323.1MIBRXImmunityBio, Inc.$113.3M668.3%310.2%$6.5B
IPSCCentury Therapeutics, Inc. (this company)$109.2M1,556.8%8.8%$294.2M
STROSutro Biopharma, Inc.$102.5M65.2%186.5%$159.0MFDMT4D Molecular Therapeutics, Inc.$85.2M230,194.6%164.4%$682.1MMGTXMeiraGTx Holdings plc$81.4M144.6%140.3%$858.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Century Therapeutics, Inc. · CIK 1850119 · Engraved from SEC EDGAR